stars 1 stars 2 stars 3

SymThera was founded in 2006 by scientists at the Weizmann Science Park, Israel, and informatics specialists from San Diego, USA. The company has developed proprietary in silico drug discovery algorithms by applying telecommunications network theory to biological systems for the treatment of inflammatory, autoimmune and metabolic diseases including diseases such as rheumatoid arthritis and diabetes. A first example of SymThera's seminal work in the filed of rheumatoid arthritis drug discovery was published in 2009.

SymThera Ltd. Questions

The SymThera Ltd. annual revenue was $5 million in 2026.

Chai Ezerzer is the CSO of SymThera Ltd..

2 people are employed at SymThera Ltd..

SymThera Ltd. is based in Toronto, Ontario.

The NAICS codes for SymThera Ltd. are [5417, 54171, 541714, 541, 54].

The SIC codes for SymThera Ltd. are [87, 873].

Top SymThera Ltd. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users